Unknown

Dataset Information

0

Secreting Germ Cell Tumors of the Central Nervous System: A Long-Term Follow-up Experience.


ABSTRACT: INTRODUCTION:Due to the rarity of nongerminomatous germ cell tumors (NGGCT) with non-standard treatment as yet, we report retrospectively our 30 year experience with chemotherapy followed by craniospinal irradiation (CSI), plus a boost of whole ventricular irradiation (WVI)/tumor bed (TB), tailored to pre-radiation chemotherapy response. METHODS:Between 1988 and 2016, 28 patients received four cycles of PEB (cisplatin/etoposide/bleomycin), then CSI, and two further PEB cycles. Between 1988 and1994, CSI was 25.5 Gy for patients in complete remission (CR), 30 Gy if in partial remission (PR) or metastatic, with a boost to TB up to 45-54 Gy. In the period of 1995-2010, the boost included WVI and any extra-ventricular tumor sites up to 45 Gy. After 2010, CSI was reduced to 25.5 Gy for all non-metastatic patients, and a boost was given only to TB up to 40.5/45.5 Gy, depending on patients' CR/PR status. After 2003, patients with alfafetoprotein (?FP) > 1000 ng/mL received intensified treatment, also including autologous stem cell transplantation. RESULTS:Among 28 patients (23 males; median age 12 years, 6 metastatic), 25 responded to PEB, and three progressed (PD) after one to four cycles; 26 received radiotherapy obtaining 13 CR, 7 PR and 5 stable disease (SD), 1 PD; 6 (21%) died (5 for disease, 1 for pneumonia while in CR). Five-year overall survival (OS) and progression-free survival (PFS) were both 81%; 10 year OS and PFS 81% and 76%, respectively (median follow-up 11 years). CONCLUSIONS:Survival for children with NGGCT, independently from disease extent, was encouraging. Further studies should elucidate which patients could benefit from reduced volume and dose irradiation.

SUBMITTER: Biassoni V 

PROVIDER: S-EPMC7565315 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Introduction</h4>Due to the rarity of nongerminomatous germ cell tumors (NGGCT) with non-standard treatment as yet, we report retrospectively our 30 year experience with chemotherapy followed by craniospinal irradiation (CSI), plus a boost of whole ventricular irradiation (WVI)/tumor bed (TB), tailored to pre-radiation chemotherapy response.<h4>Methods</h4>Between 1988 and 2016, 28 patients received four cycles of PEB (cisplatin/etoposide/bleomycin), then CSI, and two further PEB cycles. Bet  ...[more]

Similar Datasets

| S-EPMC8346457 | biostudies-literature
| S-EPMC8059842 | biostudies-literature
| S-EPMC7140092 | biostudies-literature
| S-EPMC7141506 | biostudies-literature
| S-EPMC5189979 | biostudies-literature
| S-EPMC4351928 | biostudies-literature
| S-EPMC4466539 | biostudies-literature
| S-EPMC3513540 | biostudies-literature
| S-EPMC4198764 | biostudies-literature
| S-EPMC7500618 | biostudies-literature